EV-BM-MSC/TERT2922024-04-26T08:32:52+00:00

Extracellular vesicles
from bone marrow-derived MSCs

Extracellular vesicles (EVs) play an essential role in cellular communication by transporting proteins, lipids as well as nucleic acids. EVs from our bone marrow-derived mesenchymal stromal cell line BM-MSC/TERT292 are characterized by the typical EV morphology, presence of EV marker proteins as well as anti-inflammatory and anti-fibrotic activities.

Print Friendly, PDF & Email

Order

EV-BM-MSC/TERT292

Related Products

Bone marrow-derived mesenchymal stromal cells

BM-MSC/TERT292

Related Services

Enrichment and characterization of EVs from your cell culture supernatant

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

“Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed.”

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

Related Products

adipose-derived mesenchymal stem cells

Related Services

Production and characterization of extracellular vesicles

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

“Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed.”

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

Print Friendly, PDF & Email

from

€ 1.875

EV-ASC/TERT300
Cat#: EV-001-0300-A2

Go to Top